On Friday 10 January 2025, we held a webinar on the calls launched by the ERDERA and PerMed European Partnership. We presented to the participants the conditions and rules that Czech applicants must meet in order to participate in these calls. The webinar also included a practical...
The ERDERA Partnership Coordination Team is organising another webinar on the call "Pre-clinical therapy studies for rare diseases using small molecules and biologicals - development and validation". The webinar will take place on 14 January 2025 and aims to provide educational and preparatory support to applicants...
Projects that have been approved for more than 1 year are evaluated annually through the Health Research Agency's Expert Advisory Panels (Panels) ČR (AZV) in the form of Project Milestone Reports. These are brief summaries of the individual objectives achieved over...
For projects that end on 31 December 2024, investigator submits a "Final Project Report", documenting all the facts required by the provider. Instructions for completing the Final Report can be found in the Annex to this article (see Annex Instructions for completing the Final Report for...
In connection with the announcement of calls at transnational level in the ERDERA European Partnership and the PerMed European Partnership, we have decided to organize a webinar to be held on 10 January 2025. The aim of the webinar is to inform about the conditions for the participation of Czech applicants in the call, the...
On Thursday, 19 December 2024, the Agency for Health Research ČR organised a webinar on the calls launched by the ERA4Health and THCS European Partnerships. We presented to the participants the conditions and rules that Czech applicants have to meet to participate in these calls. The webinar included...
The PerMed Partnership invites research teams from across Europe and beyond to participate in a webinar on 9 January 2025 from 13.00 to 14.30 (CET). This webinar will offer detailed information and practical guidance for those considering participating in the call entitled "Pharmacogenomic strategies for personalised...
Thank you for your cooperation this year and we wish you a peaceful Christmas, good health, well-being, energy and success in 2025!
We have prepared this year's second issue of the Agency for Health Research newsletter ČR, which summarises the most important events of the past six months. A major milestone in the life of our Agency was the approval in May of the amendment to the Programme for the Promotion of Applied Health Research 2024-2030...
On 17 December 2024, the Ministry of Health (hereinafter referred to as the "MoH") publishes, in accordance with Act No. 130/2002 Coll., on the Support of Research, Experimental Development and Innovation from Public Funds and on Amendments to Certain Related Acts (Act on the Support of Research, Experimental Development and Innovation), as amended by...